Biotechnology

Omnicanna Health Solutions, Inc. appoints Greta Gaines as President

October 9, 2020 9:30 AM

President Greta Gaines's first action as President is launching the Omnicanna's licensed real time negotiating industrial hemp eCommerce Website; www.ihemp.omnicanna.com RALEIGH, NC / ACCESSWIRE / October 9, 2020 / Omnicanna Health Solutions, Inc. (OTC PINK:ENDO), a U.S. Company specializing in hemp formulation-based health and wellness solutions, is pleased to announce the appointment of Greta Gaines as President, while launching its live...

Read more

Hancock Jaffe Engages Syntactx for VenoValve U.S. Pivotal Trial

October 8, 2020 8:30 AM

Syntactx to provide CRO Services IRVINE, CA / ACCESSWIRE / October 8, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has engaged Syntactx LLC to assist Hancock Jaffe with the VenoValve U.S. pivotal trial. Syntactx will work with Hancock Jaffe in several key areas including strategy, clinical operations, regulatory affairs, and safety,...

Read more

Milestone Scientific to Present at MicroCap Rodeo Best Ideas Bowl on October 13th

October 7, 2020 11:30 AM

ROSELAND, NJ / ACCESSWIRE / October 7, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th - 16th, 2020. Leonard Osser, Interim Chief Executive Officer, is scheduled to present on Tuesday, October 13th at 2:30 p.m.,...

Read more

ABMC to Distribute Co-Diagnostics Inc. EUA Issued Logix Smart(TM) Covid-19 Test

October 7, 2020 10:25 AM

KINDERHOOK, NY / ACCESSWIRE / October 7, 2020 / American Bio Medica Corporation (OTC PINK:ABMC) today announced they have signed a distribution agreement with Co-Diagnostics, Inc. (CODX) granting ABMC the right to market and sell the Logix Smart Covid-19 tests in the United States on a non-exclusive basis. The test operates using a single step RT-PCR process in lower respiratory tract fluid samples such as bronchoalveolar lavage, sputum,...

Read more

Hancock Jaffe Laboratories, Inc. Announces Pricing of $5.1 Million Registered Direct Offering Priced at the Market

October 7, 2020 8:30 AM

IRVINE, CA / ACCESSWIRE / October 7, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced the pricing of a registered direct offering of $5.1 million of its common stock and warrants to purchase shares of common stock in a concurrent private placement. The combined purchase price for one share of common stock and one warrant to purchase one share of common...

Read more

Optec Surpasses Previous Quarter's Income & Revenue by Over 600% for Period Ending September 30, 2020

October 7, 2020 8:00 AM

CARLSBAD, CA / ACCESSWIRE / October 7, 2020 / OPTEC International, Inc (OTC PINK:OPTI) today announced the company surpassed the financial income projections for the Quarter ending September 30, 2020. Interim (unaudited) financial overview can be found at these links: https://www.otcmarkets.com/stock/OPTI/news https://optecintl.com/investors/news/ In summary, the Company surpassed its $4,000,000 projection for this quarter and, in...

Read more

Tetra Bio-Pharma Unveils its Commercial Vision on a Robust Chemotherapy Induced Nausea and Vomiting Portfolio

October 7, 2020 8:00 AM

DIN submission to be completed in Q4 2020 OTTAWA, ON / ACCESSWIRE / October 7, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, is pleased to provide an update on its commercial strategy to bring innovative therapies to patients suffering from chemotherapy induced nausea and vomiting (CINV). Tetra will be submitting a marketing...

Read more

Nascent Biotech Announces Key Personnel Additions in Preparation for Coming Phase One Clinical Studies

October 7, 2020 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / October 7, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech" or the "Company") announces today that the Company is in the process of making significant additions to its core team in order to prepare for the initiation of key Phase One clinical trials to study the safety and efficacy of the Company's flagship drug, Pritumumab (PTB), a monoclonal antibody, for the treatment of Brain Cancer. Effective...

Read more

GB Sciences Files Provisional Patent Application for the Treatment of Chronic Inflammation Utilizing Its Novel Cannabinoid Containing Complex Mixtures (CCCM)

October 6, 2020 9:00 AM

LAS VEGAS, NV / ACCESSWIRE / October 6, 2020 / ​GB Sciences, Inc. (OTCQB:GBLX), has filed a provisional patent application, assigned to GBS Global Biopharma (GBS), Inc., for the use of its new proprietary cannabinoid containing complex mixtures (CCCM™) for the treatment of chronic inflammation. Chronic inflammation represents a serious global health and economic burden with over $130 billion spent annually.  Based on data from a two-year...

Read more

electroCore to Participate in the MicroCap Rodeo: The Best Ideas Bowl

October 6, 2020 8:00 AM

BASKING RIDGE, NJ / ACCESSWIRE / October 6, 2020 / electroCore, Inc. (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will provide a corporate update at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually October 13-16, 2020. Event details: Date: Tuesday, October 13 Time: 1:30pm ET Audio from the event will be webcast live and available here...

Read more

Hemogenyx Pharmaceuticals PLC Announces SAFE-HEMO-CAR-T Effective against AML in vitro

October 6, 2020 2:00 AM

LONDON, UK / ACCESSWIRE / October 6, 2020 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce the following update on its activities. As previously announced, Hemogenyx Pharmaceuticals' CDX bi-specific antibody has the potential to treat Acute Myeloid Leukemia ("AML") directly as well as to provide a benign conditioning regimen for blood...

Read more

Molecular Partners Demonstrates Reduction of Mortality and Potent Therapeutic Activity of Anti-COVID-19 DARPin(R) Candidates in Advanced COVID-19 Disease Model

October 6, 2020 1:00 AM

DARPin® Candidates Demonstrate 100% Survival in an Aggressive Viral Challenge Model Data Support Utility of Anti-COVID-19 DARPin® Candidates As Potent Therapeutics First-in-Human Clinical Trial Initiation of MP0420 Planned for November 2020 ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / October 6, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known...

Read more

OMNICANNA to Launch its Industrial Hemp Real-Time Trading eCommerce Website, October 9, 2020, Featuring Disruptive Real-Time Negotiating Technology, Providing All Buyers and Sellers Powerful Tools to Navigate, Find, & Track Industrial Hemp Inventory

October 5, 2020 11:38 AM

RALEIGH, NC / ACCESSWIRE / October 5, 2020 / Omnicanna Health Solutions, Inc. (OTC PINK:ENDO), a U.S. Company specializing in hemp formulation-based health and wellness solutions, is pleased to announce it will release its Industrial Hemp Real-Time Negotiating eCommerce website, October 9, 2020. Featuring Advanced Disruptive Real-Time Negotiating Technology. Providing powerful online tools to All Buyers and Sellers of Industrial Hemp...

Read more

Wuhan General Group Appoints Willem Jonker as Chief Operating Officer

October 5, 2020 9:30 AM

CAPE TOWN, SA / ACCESSWIRE / October 5, 2020 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is delighted to share today the appointment of Mr. Willem Jonker, CA(SA), as Chief Operating Officer of the Cannabis Cultivation Project effective immediately. Willem is an experienced leader and a recognized international...

Read more

Qrons files U.S. National Phase of its Patent Application

October 5, 2020 9:00 AM

NEW YORK, NY / ACCESSWIRE / October 5, 2020 / Qrons Inc. (OTCQB:QRON), an emerging biotechnology company developing advanced stem cell-synthetic hydrogel-based solutions for the treatment of traumatic brain injuries (TBIs) and other nervous system pathologies, today announced that it has filed in the United States Patent and Trademark Office (USPTO), the US National Phase of its international (PCT) patent application, thereby initiating Qrons'...

Read more

Havn Life Sciences Announces Appointments of Vic Neufeld as Chairman and Rick Brar as Vice Chairman of the Board of Directors, Respectively, and the Acceleration of Warrants

October 5, 2020 8:00 AM

VANCOUVER, BC / ACCESSWIRE / October 5, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the "Company" or "Havn Life") is pleased to announce that Mr. Vic Neufeld has been appointed as the Chairman of the Board of Directors of the Company (the "Board"). Mr. Neufeld brings a wealth of knowledge and experience in the Natural Health Food industry, having served as the Chief Executive Officer of Jamieson Laboratories ("Jamieson"), Canada's...

Read more

Enzolytics, Inc. Announces New Board Member, Charles Cotropia, CEO of BioClonetics Immunotherapeutics, Inc. Harry Zhabilov CEO of Enzolytics to Join Board of BioClonetics

October 1, 2020 9:00 AM

PLANO, TX / ACCESSWIRE / October 1, 2020 / Enzolytics, Inc. (OTC PINK:ENZC) or (the "Company") today announced the addition of Charles Cotropia to the Company's Board of Directors. ENZC entered into a Letter of Intent (the "LOI") to merge with BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics"), a biotech company located in Dallas Texas, on September 15, 2020. In addition, the Company announces that Harry Zhabilov, CEO of ENZC will...

Read more

Nascent Biotech Continues to Reduce Liabilities by Over $2.0 Million Dollars

October 1, 2020 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / October 1, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) Announced today that It has continued to reduce its liabilities through stock conversion and payment of accounts payable and accrued liabilities. The reduction was achieved through the conversion of debt to equity and the reduction of liabilities, including its last convertible note. The convertible note's principal is now $11,250 down from $161,250, a reduction of...

Read more

ITOCO Completes Blockchain Smart Contract for Immutable Virus Test Result Verification System

October 1, 2020 7:00 AM

TORONTO, ON / ACCESSWIRE / October 1, 2020 / ITOCO INC. (OTC PINK:ITMC) has successfully completed and deployed the blockchain portion of its patent-pending Immutable Virus Test Result Verification System to the Ethereum Ropsten test network. This important first step in commercializing the patent-pending technology, acquired through its previously announced agreement with DATANet Software, and making it available to prospective clients and...

Read more

Vitro Biopharma 3rd Quarter ended July 31st 2020 Financial Results of Operations

October 1, 2020 6:00 AM

GOLDEN, CO / ACCESSWIRE / October 1, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced its 3rd quarter, ended July 31st 2020, financial results of operations. Vitro Biopharma recorded 3rd quarter revenues of $132,066 vs $225,191 a decrease of 41% over the comparative quarter last year. Revenues were up slightly from the prior quarter which were $128,631. The decrease in revenue is directly attributed to the COVID 19...

Read more